Research materials with lot-level documentation.

Small-molecule NNMT inhibitor used as a chemical probe in adipocyte and methylation research.

Up to 72% lower per mg

Amidated Semax analog studied as a stability-modified variant in neuropeptide research.

Modified growth-hormone fragment (176–191) studied in adipocyte and lipid-metabolism research models.

Up to 19% lower per mg

Eleven-residue erythropoietin-derived peptide studied for innate repair receptor signaling.

Cobalt-containing cobalamin cofactor supplied for one-carbon metabolism and enzyme research.

Sterile water with 0.9% benzyl alcohol, supplied as a laboratory reconstitution solution.

Up to 62% lower per mL

Long-acting amylin analog studied for amylin and calcitonin receptor signaling in laboratory models.

Research blend pairing an amylin analog with a GLP-1 receptor agonist for combined-pathway studies.

Short synthetic bioregulator tripeptide studied in connective-tissue and gene-expression models.

Modified GHRH (1–29) analog without albumin binding, used as a short-duration receptor reference.

Combined GHRH analog and secretagogue receptor agonist preparation for dual-input pituitary research.

GHRH analog with Drug Affinity Complex modification for extended-duration receptor research.

Angiotensin IV-derived small molecule studied for HGF/c-Met signaling in neuronal research.

Nonapeptide isolated from cerebral venous blood, studied in neuropeptide and sleep-physiology research.

Synthetic tetrapeptide studied for telomerase expression and pineal peptide research in cell models.

Up to 60% lower per mg

Retro-inverso FOXO4 peptide studied for p53 interaction in cellular senescence research.

Copper-binding tripeptide complex studied in fibroblast, matrix, and gene-expression research.

Up to 31% lower per mg

Second-generation growth hormone releasing peptide studied as a ghrelin receptor agonist reference.

Early growth hormone releasing hexapeptide widely cited as a ghrelin receptor research standard.

Glycoprotein gonadotropin studied for LH/CG receptor signaling in reproductive endocrinology research.

Up to 30% lower per IU

Unmodified C-terminal growth-hormone fragment used in comparative adipose-tissue research.

Gonadotropin preparation with FSH and LH activity used in reproductive endocrinology research models.

Long R3 IGF-1 analog with reduced binding-protein affinity for cell-culture signaling research.

Selective growth hormone secretagogue receptor agonist pentapeptide used in receptor-selectivity research.

Up to 37% lower per mg

Ipamorelin-forward research blend with a stabilized GHRH analog for secretagogue pathway studies.

KISS1R ligand peptide studied as an upstream regulator of the reproductive neuroendocrine axis.

Multi-peptide research blend pairing an inflammatory-pathway fragment with structural research peptides.

Alpha-MSH C-terminal tripeptide studied for inflammatory signaling in cellular research models.

Quaternary ammonium compound studied for fatty-acid transport and mitochondrial metabolism research.

Endogenous tripeptide antioxidant supplied for redox balance and oxidative-stress research.

Up to 50% lower per mg

Combined lipotropic compound preparation supplied for laboratory metabolic research applications.

Human cathelicidin-derived antimicrobial peptide studied in innate immunity and membrane research.

Alpha-MSH analog with MC1R selectivity used in melanocortin receptor and pigmentation research.

Cyclic non-selective melanocortin agonist used in receptor pharmacology and comparative research.

Mitochondrial-derived peptide studied in AMPK signaling and metabolic homeostasis research.

Up to 42% lower per mg

Essential redox coenzyme supplied for cellular metabolism, sirtuin, and mitochondrial research.

Up to 25% lower per mg

Nine-residue neurohypophysial peptide studied for oxytocin receptor signaling and social-behavior models.

Short synthetic tripeptide from the bioregulator series studied in neuronal cell-culture models.

MC4R-preferring melanocortin peptide studied for central receptor signaling in preclinical models.

Research blend combining a triple receptor agonist with an amylin analog for multi-pathway models.

Tuftsin analog heptapeptide studied in neuroimmune and GABAergic gene-expression research.

Long-acting GLP-1 receptor agonist analog studied in preclinical metabolic and incretin-signaling models.

Up to 62% lower per mg

ACTH (4–10) heptapeptide analog studied for BDNF expression and neurotrophic signaling research.

Up to 43% lower per mg

Combined preparation of two stabilized neuropeptides for parallel neurotrophic and neuroimmune studies.

GHRH (1–29) fragment studied as the minimal active sequence for GHRH receptor research.

Octapeptide SNARE-complex fragment analog studied in vesicle-fusion and neurosecretion research.

Cardiolipin-binding tetrapeptide studied for mitochondrial membrane and bioenergetics research.

Up to 50% lower per mg

Synthetic thymosin beta-4 fragment studied for actin binding and cytoskeletal research applications.

Up to 33% lower per mg

Stabilized GHRH analog studied for growth-hormone-releasing hormone receptor signaling in preclinical models.

Up to 14% lower per mg

Research blend of a GHRH analog and a selective ghrelin-receptor agonist for dual-pathway studies.

Up to 20% lower per mg

28-residue thymic peptide studied for toll-like receptor engagement and immune-signaling research.

Dual GIP and GLP-1 receptor agonist peptide used in comparative incretin-signaling research.

Up to 46% lower per mg

28-residue neuropeptide studied for VPAC receptor signaling in neuroimmune and secretory research.